ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,514Medicare Part D Prescriptions Filled, Including Refills

Rank: 22 out of 617

$744K Total Retail Price of All Prescriptions

Rank: 19 out of 617

549 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
32% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 549 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

15% of this provider’s 549 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

0% of this provider’s 13,305 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
OMEPRAZOLE 683 632 1 3
SIMVASTATIN 553 533 2 2
LEVOTHYROXINE SODIUM 487 469 3 1
FUROSEMIDE 467 448 4 4
SPIRONOLACTONE 425 415 5 42
WARFARIN SODIUM 407 403 6 7
LISINOPRIL 326 299 7 5
RANITIDINE HCL 323 293 8 40
HYDROCODONE-ACETAMINOPHEN 305 236 S3 9 8
AMLODIPINE BESYLATE 279 267 10 6
METFORMIN HCL 252 228 11 9
TAMSULOSIN HCL 242 232 12 26
ZOLPIDEM TARTRATE 230 198 13 23
ATENOLOL 224 220 14 17
TRAMADOL HCL 222 204 15 15
CARVEDILOL 220 192 16 19
SERTRALINE HCL 207 186 17 20
GABAPENTIN 205 203 18 16
LISINOPRIL-HYDROCHLOROTHIAZIDE 202 193 19 29
PRAVASTATIN SODIUM 195 181 20 21
EVISTA 179 179 21 119
METOPROLOL SUCCINATE 174 174 22 12
CYMBALTA 172 148 23 49
DIGOXIN 168 154 24 48
ALLOPURINOL 157 156 25 27
METOPROLOL TARTRATE 152 145 26 11
LOSARTAN POTASSIUM 152 127 26 22
CITALOPRAM HBR 144 126 28 18
RISPERIDONE 141 127 29 71
PREDNISONE 131 107 30 31
DIOVAN HCT 128 126 31 97
MELOXICAM 122 114 32 24
NAMENDA 119 119 33 35
FENOFIBRATE 117 107 34 58
BYSTOLIC 117 117 34 64
LOSARTAN-HYDROCHLOROTHIAZIDE 115 112 36 46
DIOVAN 113 110 37 41
AMIODARONE HCL 110 110 38 129
POLYETHYLENE GLYCOL 3350 101 99 39 32
CRESTOR 91 84 40 28
GLIMEPIRIDE 88 86 41 33
FLUOXETINE HCL 87 86 42 73
HYDROCHLOROTHIAZIDE 86 86 43 13
VENLAFAXINE HCL ER 84 84 44 76
ALENDRONATE SODIUM 82 78 45 25
CLOPIDOGREL 81 74 46 53
DONEPEZIL HCL 78 78 47 30
MUPIROCIN 76 75 48 176
LEVOFLOXACIN 74 61 49 89
CIPROFLOXACIN HCL 67 60 50 60
CARBIDOPA-LEVODOPA 66 57 51 69
CELEBREX 66 58 51 63
NEXIUM 63 55 53 43
PLAVIX 63 63 53 86
SINGULAIR 63 60 53 106
ATORVASTATIN CALCIUM 63 58 53 14
ZETIA 62 53 57 77
POTASSIUM CHLORIDE 62 56 57 10
RAMIPRIL 61 61 59 67
PRAMIPEXOLE DIHYDROCHLORIDE 60 50 60 153
SPIRONOLACTONE-HCTZ 59 59 61 189
BETHANECHOL CHLORIDE 59 59 61 291
FINASTERIDE 59 59 61 104
ADVAIR DISKUS 57 57 64 38
DIVALPROEX SODIUM 56 42 65 111
DILTIAZEM ER 50 49 66 81
PRENATAL PLUS 50 38 66 243
TOPIRAMATE 50 24 66 149
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 18, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.